(Date:7/3/2009)...ding will lead to treatments, , , FRIDA...y they,ve found a major cellular flaw that may dri...When caught early, lung cancer can often be treate...se is well advanced. Though doctors can sometimes ...prings back more virulent than ever, frequently sp...
(Date:7/3/2009)...ire-Asia/ -- Sundia MediTech, a leading,integrate...ompany in Shanghai,China announced today that Dr...ent of Chemistry Services. , Prior to joini...es, a drug,discovery and development company in S...t to Senior Director of Medicinal Chemistry of Neu...
(Date:7/3/2009)...panies and three individuals have been recognized ...tional competition designed to reward workplace he...tyXChange.org community released its 2009 Saxcies ...ww.safetyxchange.org/saxcies-video . The winners a...te their lives to keeping others safe - are detail...
(Date:7/3/2009)...Whitaker, MD, a founder of the alternative health ...ain.com, a new informational Web site devoted to a...tions. , Potomac, MD (Voc... of the alternative health movement, is now a feat...ional Web site devoted to all aspects of joint and...
Breaking Medicine News(10 mins):Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2...of a recent study researchers say that the circadi...epeat in 24-hour cycles , can significantly impact...ercise // or receive medical treatments . During t...n 8:00 a.m. and 5:00 p.m were examined. Results f...
... the most common cancer among men, affecting about...d 220,000 new cases // of the disease are diagnose...te cancer every year. New research shows men who a...lining of their prostate ducts run a high risk of ...
...ws that people who suffer from sleep apnea run a h...sia administered // during surgery . Sleep apnea i...iodically during sleep . Statistics show the most ...obstructive sleep apnea, affects as many as 4 perc...
...a laugh signifies more than humor and ridicule, re...cal evidence // of the role of laughter during psy...e about communicating emotion than about humor. Re...s and took physiological measurements of both memb...
Other Medicine News:(Date:6/29/2009)...for Novel Biotherapeutics Based On Naturally Resec...RNewswire/ -- Pangu BioPharma, a subsidiary of aTy...of its third patent application on proprietary, na.... Although tRNA synthetases are universal and ess...ound in all organisms, human synthetases have natu...
(Date:6/26/2009)...e 26, and OSAKA, Japan, June 27, 2009 /PRNewswire/...") today announced that Takeda Global Research &am... States (U.S.) subsidiary received on June 26 (U.S...ood and Drug Administration (FDA) regarding the Co... a selective dipeptidyl peptidase IV (DPP-4) inhib...
(Date:6/25/2009)...Medical Experts Slated to Attend First National Sy...re/ -- The first national symposium designed to ex...held next week in New York City when thirteen top ...om their respective fields. The SUNY Youth Sports... the health impacts that the $5 billion-a-year ene...
(Date:6/24/2009)...e 25 In a revolutionary healthcare... in the British Journal of Nutrition (a Cambridge...tics reduce cholesterol and triglycerides, contr..., The controlled clinical study was conducted on ...n 80% survival rate to 24 months versus a 50% surv...
Breaking Medicine Technology:Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 4New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33% 2Education and progress at the 24th Annual EAU Congress in Stockholm 38671 1Education and progress at the 24th Annual EAU Congress in Stockholm 38671 2Stem cell breakthrough gives new hope to sufferers of muscle wasting diseases 7401 1Stem cell breakthrough gives new hope to sufferers of muscle wasting diseases 7401 2Magnetic nanoparticles navigate therapeutic genes through the body 7398 1NYU College of Dentistry awarded 241 9 million NIH grant for HIV research 7395 1NYU College of Dentistry awarded 241 9 million NIH grant for HIV research 7395 2...2007 /PRNewswire-FirstCall/ --,Telik, Inc. announc... Phase 2 trial of the triplet combination of TELCY...paclitaxel will be,presented at the 98th annual me...rch (AACR) in Los Angeles. Preclinical studies of,...ancer cell growth,inhibition with TELCYTA in combi...
...2007 /PRNewswire-FirstCall/ --,Pharmacyclics, Inc....its novel histone deacetylase (HDAC) inhibitor and... presentations,will take place at the American Ass...eting being held April 14-18, 2007, at the Los,Ang... The presentations are as follows:, Sunday, A...
Other Medicine Technology:Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 2Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 3Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 4Liquichek Hematology-8 Control is a whole blood hematology control with extended stability for non-differential analyzers.
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
Built on the market leading optical performance of the OMEGA 180, the OMEGA 500 has been optimized for even better views of the fundus. A new multi-coated illumination system, including a new XHL Xen
Medicine Products: